{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:07:43Z","timestamp":1779912463792,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.peptides.2020.170421","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T11:54:37Z","timestamp":1602503677000},"page":"170421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of Enhanced Lipid Oxidation and Compensatory Suppression using Natriuretic Peptide in Patients with Cardiovascular Diseases"],"prefix":"10.1016","volume":"135","author":[{"given":"Jun","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu D.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Nagoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Minai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.peptides.2020.170421_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/hrt.65.5.245","article-title":"Oxygen free radicals and congestive heart failure","volume":"65","author":"Belch","year":"1991","journal-title":"British heart journal"},{"issue":"7","key":"10.1016\/j.peptides.2020.170421_bib0010","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.CIR.96.7.2414","article-title":"Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction","volume":"96","author":"Hill","year":"1997","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.peptides.2020.170421_bib0015","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.97.16.1536","article-title":"Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure","volume":"97","author":"Mallat","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.peptides.2020.170421_bib0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of Mitochondrial Transhydrogenase Causes Oxidative Stress in Heart Failure","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell metabolism"},{"issue":"5","key":"10.1016\/j.peptides.2020.170421_bib0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jjcc.2014.02.016","article-title":"Association of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failure","volume":"64","author":"Otaki","year":"2014","journal-title":"Journal of cardiology"},{"issue":"6","key":"10.1016\/j.peptides.2020.170421_bib0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1253\/jcj.65.491","article-title":"Serum thioredoxin (TRX) levels in patients with heart failure","volume":"65","author":"Kishimoto","year":"2001","journal-title":"Japanese circulation journal"},{"key":"10.1016\/j.peptides.2020.170421_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2016.11.077","article-title":"Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure","volume":"228","author":"Otaki","year":"2017","journal-title":"International journal of cardiology"},{"issue":"24","key":"10.1016\/j.peptides.2020.170421_bib0040","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","article-title":"Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase","volume":"106","author":"Landmesser","year":"2002","journal-title":"Circulation"},{"issue":"1-2","key":"10.1016\/j.peptides.2020.170421_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0005-2760(94)90100-7","article-title":"Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum","volume":"1215","author":"Kotani","year":"1994","journal-title":"Biochimica et biophysica acta"},{"issue":"5","key":"10.1016\/j.peptides.2020.170421_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.ATV.21.5.844","article-title":"Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease","volume":"21","author":"Holvoet","year":"2001","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"4","key":"10.1016\/j.peptides.2020.170421_bib0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.ATV.0000012351.63938.84","article-title":"Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles, Arteriosclerosis, thrombosis","volume":"22","author":"Tanaga","year":"2002","journal-title":"and vascular biology"},{"issue":"1","key":"10.1016\/j.peptides.2020.170421_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2004.09.013","article-title":"Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease","volume":"179","author":"Miyazaki","year":"2005","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.peptides.2020.170421_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181206","article-title":"Conflicting relationship between age-dependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide","volume":"12","author":"Fukumoto","year":"2017","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.peptides.2020.170421_bib0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2169\/internalmedicine.53.9549","article-title":"Association of coronary artery calcification with MDA-LDL-C\/LDL-C and urinary 8-isoprostane in Japanese patients with type 2 diabetes","volume":"53","author":"Ono","year":"2014","journal-title":"Internal medicine (Tokyo, Japan)"},{"issue":"6159","key":"10.1016\/j.peptides.2020.170421_bib0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.peptides.2020.170421_bib0080","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"10.1016\/j.peptides.2020.170421_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","article-title":"Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure","volume":"90","author":"Yasue","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.peptides.2020.170421_bib0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.CIR.76.1.115","article-title":"Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function","volume":"76","author":"Saito","year":"1987","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.peptides.2020.170421_bib0095","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/01.CIR.84.4.1581","article-title":"Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure","volume":"84","author":"Yoshimura","year":"1991","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.peptides.2020.170421_bib0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.RES.63.6.987","article-title":"Effects of alpha-human atrial natriuretic peptide on the interrelationship of arterial pressure, aortic nerve activity, and aortic diameter","volume":"63","author":"Hirooka","year":"1988","journal-title":"Circulation research"},{"issue":"9","key":"10.1016\/j.peptides.2020.170421_bib0105","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00259-014-2754-2","article-title":"Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide","volume":"41","author":"Kasama","year":"2014","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"2","key":"10.1016\/j.peptides.2020.170421_bib0110","first-page":"171","article-title":"Determination of the B-type natriuretic peptide level as a criterion for abnormalities in Japanese individuals in routine clinical practice: the J-ABS Multi-Center Study (Japan Abnormal BNP Standard), Internal medicine (Tokyo","volume":"52","author":"Kawai","year":"2013","journal-title":"Japan)"},{"issue":"22","key":"10.1016\/j.peptides.2020.170421_bib0115","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/01.CIR.0000070953.76250.B9","article-title":"B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction","volume":"107","author":"Richards","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.peptides.2020.170421_bib0120","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/01.CIR.0000141295.60857.30","article-title":"Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis","volume":"110","author":"Suzuki","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.peptides.2020.170421_bib0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"Suppl 3(Suppl 3)","key":"10.1016\/j.peptides.2020.170421_bib0130","article-title":"The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages","volume":"60","author":"Kiemer","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"10.1016\/j.peptides.2020.170421_bib0135","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1073\/pnas.1321232111","article-title":"Reactive cysteine persulfides and S-polythiolation regulate oxidative stress and redox signaling","volume":"111","author":"Ida","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.peptides.2020.170421_bib0140","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.neuint.2013.01.019","article-title":"Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicity","volume":"62","author":"Albrecht","year":"2013","journal-title":"Neurochemistry international"},{"issue":"4","key":"10.1016\/j.peptides.2020.170421_bib0145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1139\/cjpp-2016-0298","article-title":"Age-related changes to vascular protease-activated receptor 2 in metabolic syndrome: a relationship between oxidative stress, receptor expression, and endothelium-dependent vasodilation","volume":"95","author":"Maruyama","year":"2017","journal-title":"Canadian journal of physiology and pharmacology"},{"issue":"7","key":"10.1016\/j.peptides.2020.170421_bib0150","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1253\/circj.71.1040","article-title":"Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure","volume":"71","author":"Shono","year":"2007","journal-title":"Circulation journal : official journal of the Japanese Circulation Society"},{"issue":"1-3","key":"10.1016\/j.peptides.2020.170421_bib0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.regpep.2008.02.009","article-title":"Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages","volume":"148","author":"Chiurchiu","year":"2008","journal-title":"Regulatory peptides"},{"issue":"4","key":"10.1016\/j.peptides.2020.170421_bib0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/FJC.0b013e318031f07f","article-title":"Carvedilol reduces elevated B-type natriuretic peptide in dialyzed patients without heart failure: cardioprotective effect of the beta-blocker","volume":"49","author":"Kojima","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.peptides.2020.170421_bib0165","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41598-020-59309-4","article-title":"A Highly-sensitized Response of B-type Natriuretic Peptide to Cardiac Ischaemia Quantified by Intracoronary Pressure Measurements","volume":"10","author":"Itakura","year":"2020","journal-title":"Scientific reports"},{"issue":"1","key":"10.1016\/j.peptides.2020.170421_bib0170","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41598-018-23441-z","article-title":"Increased Levels of Cardiac Troponin I in Subjects with Extremely Low B-type Natriuretic Peptide Levels","volume":"8","author":"Sugawa","year":"2018","journal-title":"Scientific reports"},{"issue":"5","key":"10.1016\/j.peptides.2020.170421_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177327","article-title":"Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor","volume":"12","author":"Tsutsumi","year":"2017","journal-title":"PloS one"},{"issue":"7","key":"10.1016\/j.peptides.2020.170421_bib0180","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.metabol.2007.01.018","article-title":"Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease","volume":"56","author":"Lautamaki","year":"2007","journal-title":"Metabolism: clinical and experimental"},{"issue":"22","key":"10.1016\/j.peptides.2020.170421_bib0185","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.jacc.2009.02.038","article-title":"Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure","volume":"53","author":"Tsukamoto","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.peptides.2020.170421_bib0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005455","article-title":"Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study","volume":"5","author":"Ogawa","year":"2015","journal-title":"BMJ open"},{"key":"10.1016\/j.peptides.2020.170421_bib0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.peptides.2018.08.006","article-title":"Natriuretic peptides in human heart: Novel insight into their molecular forms, functions, and diagnostic use","volume":"111","author":"Matsuo","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2020.170421_bib0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.peptides.2018.05.012","article-title":"Atrial and brain natriuretic peptides: Hormones secreted from the heart","volume":"111","author":"Nakagawa","year":"2019","journal-title":"Peptides"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:28:10Z","timestamp":1759310890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978120301704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"alternative-id":["S0196978120301704"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170421","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Enhanced Lipid Oxidation and Compensatory Suppression using Natriuretic Peptide in Patients with Cardiovascular Diseases","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170421"}}